[{"Assets_0_Q3_USD":1024202000.0,"CommonStockSharesOutstanding_0_Q3_shares":41382429.0,"EarningsPerShareBasic_1_Q3_USD":0.81,"EarningsPerShareBasic_3_Q3_USD":1.19,"EarningsPerShareDiluted_1_Q3_USD":0.68,"EarningsPerShareDiluted_3_Q3_USD":1.03,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":129188000.0,"NetIncomeLoss_1_Q3_USD":33551000.0,"NetIncomeLoss_3_Q3_USD":48652000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":50467829.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":50090088.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":41222504.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":40989813.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20171103"}]